Effect of tixagevimab/cilgavimab for pre-exposure prophylaxis during the China Omicron outbreak
Description
CONCLUSION: Tixagevimab/cilgavimab may have protected high-risk populations against infection with the Omicron variant, hospitalization and severe disease during the China COVID-19 pandemic.
